FDA grants IDE to RTI Surgical for breast reconstruction device trial
The US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) to RTI Surgical’s allograft dermis, opening the…
27 Nov 2023
FDA clears BrainSpec’s AI-powered MRS platform
The US Food and Drug Administration (FDA) has cleared BrainSpec’s magnetic resonance spectroscopy (MRS) platform, meaning clinicians will now have access to the artificial intelligence (AI)-powered software that measures brain…
27 Nov 2023
GE HealthCare debut new AI tech at RSNA 2023
GE HealthCare is exhibiting more than 40 new innovations during the Radiological Society of North America’s (RSNA) Annual Meeting in Chicago, 26-30 November 2023. The range of innovations aim to address…
27 Nov 2023
Telehealth app pledges to cut winter hospitalisations by 52%
Home-based healthcare provider, Cera, has committed to saving the UK’s National Health Service (NHS) £100m ($126m) using virtual consultations employing artificial intelligence (AI) to reduce hospitalisations. The telehealth app has…
27 Nov 2023
Roche expands Elecsys portfolio and launches Hepatitis B immunoassay
Roche has launched a qualitative and quantitative immunoassay, Elecsys HBeAg quant, to diagnose and monitor hepatitis B. The test can detect the presence of hepatitis B e antigen (HBeAg) in…
27 Nov 2023
SHL Telemedicine launches SmartHeart membership in US
SHL Telemedicine is launching a membership programme in the US for its SmartHeart device to treat post-myocardial infarction (MI) patients. SmartHeart is a battery-powered device with a 12-lead electrocardiogram (ECG)…
27 Nov 2023
OrbusNeich acquires majority stake in PT Revass
OrbusNeich Medical Group Holdings, through its wholly owned subsidiary, has acquired an 84% stake in Indonesian distributor PT Revass Utama Medika. The initial estimated amount for this deal is $15.12m.…